Pharmaceutical Technology

JANUARY 23, 2023

Out of the seven biologics approved to treat moderate to severe CD in adults, only the anti-TNFαs, Remicade (infliximab), and Humira (adalimumab), have been approved for paediatric patients, with Humira receiving the most recent approval in 2014.

Medical 59

Medical Ethics Specialization Physicians 59

pharmaphorum

DECEMBER 14, 2022

In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”

Competition 95

Competition FDA Pharmaceutical Marketing 95

European Pharmaceutical Review

FEBRUARY 7, 2023

Regulation of clinical trials Eight years following its adoption in 2014, the Clinical Trials Regulation 536/2014 (CTR) entered into application on 31 January 2022. In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR.

Medical 117

Medical Government Marketing Medicine 117

European Pharmaceutical Review

DECEMBER 19, 2023

16 Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions” Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions. Injection Safety Fact Sheet. at 100°C for 24 hours.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111

pharmaphorum

OCTOBER 26, 2022

Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An But rare diseases are a particularly important and challenging focus area.

Patients 77

Patients Pharma Consulting Transportation 77

Evolve Your Success

FEBRUARY 6, 2024

— Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland. I left them in 2014 to start our own thing. Patient safety is to do no harm. Probably right around it.

Medical sales 59

Medical sales Medical Sales Doctors 59

Clarify Health

MARCH 15, 2023

And frankly, if you’re paying a provider 57% of the 2014 CMS schedule, they’re not going to be terribly excited about you putting this bonus program in front of them when they’re concentrating on that. But at the same time, specialists especially are incredibly special, right? Sorry, that was a loaded question.

Management 52

Management Patients Physicians Government 52